EUVIMEDEUVIMED entdecken
Crossref

Major reduction in occurrence of anti‐c and anti‐E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c‐matching

Jessie S Luken iD, Claudia C Folman iD, Johan H Meekers iD, Michael V Lukens, C Ellen van der Schoot iD, Masja de Haas iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19740 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Jessie S Luken und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunohaematology Diagnostic Services, Sanquin Diagnostic Services, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Isoantibodies, Erythroblastosis, Fetal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extension with cE‐matching of the transfusion policy for women under 45 years to prevent alloimmunization and hemolytic disease of the foetus and newborn (HDFN) was evaluated. After implementation of cEK‐matching, anti‐c occurrence decreased from 46.8 to 30.4 per 100 000 pregnancies (RR 0.65, 95% CI 0.54–0.79), while anti‐E occurrence decreased from 122.1 to 89.9 per 100 000 pregnancies (RR 0.74, 95% CI 0.66–0.84). The c‐negative women showed a higher anti‐E occurrence before cEK‐matching and a more pronounced decline with the new policy. This indicates that cEK‐matched transfusion effectively reduces alloimmunization, and that a cK‐matched approach could prevent most transfusion‐related alloimmunization and HDFN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoantibodiesErythroblastosis, FetalHumansFemalePregnancyAdultBlood Group IncompatibilityBlood Grouping and CrossmatchingBlood TransfusionInfant, NewbornMiddle AgedRh-Hr Blood-Group SystemTransfusion Reaction

Stichwörter der Autor:innen

hemolytic disease of the fetus and newbornimmunohaematologypregnancyred cell antigenstransfusion

Substanzen

IsoantibodiesRh-Hr Blood-Group System

Autor:innen und Institutionen

  • Department of Immunohaematology Diagnostic Services, Sanquin Diagnostic Services, Amsterdam, The Netherlands.
  • Department of Laboratory Medicine, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
  • Department of Experimental Immunohaematology, Sanquin Research, Amsterdam, The Netherlands.
  • Sanquin Research and Landsteiner Laboratory Amsterdam UMC, Amsterdam, The Netherlands.
  • Department of Hematology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.

ORCID-Profile: Jessie S Luken, Claudia C Folman, Johan H Meekers, C Ellen van der Schoot, Masja de Haas

Zitieren

APA

Luken, J. S., Folman, C. C., Meekers, J. H., Lukens, M. V., van der Schoot, C. E., & de Haas, M. (2024). Major reduction in occurrence of anti‐c and anti‐E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c‐matching. British Journal of Haematology. https://doi.org/10.1111/bjh.19740

Vancouver

Luken JS, Folman CC, Meekers JH, Lukens MV, van der Schoot CE, de Haas M. Major reduction in occurrence of anti‐c and anti‐E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c‐matching. British Journal of Haematology. 2024. doi:10.1111/bjh.19740

BibTeX
@article{Luken2024,
  author = {Luken, Jessie S and Folman, Claudia C and Meekers, Johan H and Lukens, Michael V and van der Schoot, C Ellen and de Haas, Masja},
  title = {Major reduction in occurrence of anti‐c and anti‐E in pregnancy after more than 10 years of preventive matched transfusion with most benefit for c‐matching},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19740}
}
Kostenlos starten →